Schroder Investment Management Group
XENT

Schroder Investment Management Group’s Intersect ENT, Inc XENT Stock Holding History

Schroder Investment Management Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-257,691
Closed -$3.12M – 1281
2016
Q4 		$3.12M Sell
257,691
-46,509
-15% -$602K 0.01% 775
2016
Q3 		$4.82M Hold
304,200
– – 0.01% 732
2016
Q2 		$3.93M Hold
304,200
– – 0.01% 747
2016
Q1 		$5.62M Hold
304,200
– – 0.01% 677
2015
Q4 		$6.84M Buy
+304,200
New +$6.01M 0.01% 687

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Schroder Investment Management Group's XENT Position: Q1 2017 in Review

Schroder Investment Management Group sold out of Intersect ENT, Inc (XENT) in Q1 2017, closing a stake of 257,691 shares — an estimated $3.12M sold.

Schroder Investment Management Group first reported a position in XENT in Q4 2015 and held it in 5 quarters. The position peaked at $6.84M in Q4 2015. 106 funds tracked by Wall St. Rank hold XENT as of Q1 2017.

  • Schroder Investment Management Group reported no remaining Intersect ENT, Inc position as of Q1 2017 after selling out during the quarter.
  • Schroder Investment Management Group sold 257,691 Intersect ENT, Inc shares in Q1 2017, an estimated $3.12M.
  • Schroder Investment Management Group first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 5 quarters.
  • Schroder Investment Management Group's Intersect ENT, Inc position peaked at $6.84M in Q4 2015.
  • 106 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2017.

Based on Schroder Investment Management Group's 13F filing for Q1 2017, filed 10 May 2017.